Literature DB >> 29296056

Leptin as an independent marker of metabolic syndrome.

Beuy Joob1, Viroj Wiwanitkit2.   

Abstract

Entities:  

Year:  2017        PMID: 29296056      PMCID: PMC5740700          DOI: 10.4103/tcmj.tcmj_48_17

Source DB:  PubMed          Journal:  Ci Ji Yi Xue Za Zhi        ISSN: 1016-3190


× No keyword cloud information.
Dear Editor, The publication on “Leptin as an independent marker of metabolic syndrome” by Tseng et al. is very interesting [1]. Tseng et al. concluded that “Serum leptin is positively correlated with MetS. It serves as an independent marker of MetS in elderly patients with T2DM [1].” In fact, the usefulness of serum leptin is widely mentioned. Nevertheless, there are many possible confounding factors that might disturb the determination. First, exercise can result in lowering leptin level [2]. Second, in the case with underlying liver problem and abnormal elevated bilirubin level (such as in cases with chronic hepatitis), the interference on leptin level measurement is possible [3]. Hence, the patients with underlying hepatitis should be excluded from the study. These factors have to be concerned in the study by Tseng et al. [1].

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  3 in total

1.  Clinical evaluation of a new non-isotopic leptin immunoassay.

Authors:  A Theriault; T Agdinaoay; N B Ladao; H Chang; A Grandinetti
Journal:  Clin Lab Sci       Date:  2001

2.  The response of circulating leptin levels to exercise stress testing in subjects diagnosed with metabolic syndrome.

Authors:  Dana Pop; Alexandra Dădârlat; Gyorgy Bodizs; Liana Stanca; Dumitru Zdrenghea
Journal:  ISRN Endocrinol       Date:  2014-01-28

3.  Leptin is an independent marker of metabolic syndrome in elderly adults with type 2 diabetes.

Authors:  Pei-Wei Tseng; Du-An Wu; Jia-Sian Hou; Bang-Gee Hsu
Journal:  Ci Ji Yi Xue Za Zhi       Date:  2017 Apr-Jun
  3 in total
  1 in total

1.  Serum leptin levels and peripheral arterial stiffness in patients with type 2 diabetes.

Authors:  Sora Yasri; Viroj Wiwanitkit
Journal:  Ci Ji Yi Xue Za Zhi       Date:  2019-09-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.